Zuna J.:
The Role of TEL and AML1 Genes in Pathogenesis of Haematological Malignancies
|
131 |
Hora M., Ouda Z.:
Priapism
|
131 |
†Šobra J., Češka R.:
Genetic Predisposition for Multiple Metabolic Syndrome - Part 3: Lipid, Lipoprotein and
Apolipoprotein Metabolism
|
136 |
Mladosievičová B.:
After-Effects of the Cytostatic Therapy in Cardiology
|
138 |
Krajčovičová-Kudláčková M., Ginter E.,:
Nutritional Status of Adults on Alternative or on
Traditional Diet
|
142 |
Třeška V.,
1
Topolčan O.,
2
Kočová J.,
2
Pecen L.,
3
Tonar Z.:
Procollagen Type I and III in Patients with an Aneurysm of the
Abdominal Aorta
|
142 |
Šídlová K., Slaměník M., Juklová J., Průša R.:
Significance of Serum Cystatine C Levels Examination in Paediatric
Patients with the Renal Impairment
|
147 |
Kubešová, H., Penka, M., Král, Z., Vášová, I., Hájek, R., Adam, Z., Navrátil, M.:
Warning Symptoms Preceding the Development of Septic Shock in
Neutropenic Patients Treated on Acoount of Haematological Malignities
|
147 |
Kořenek J.:
Ethos in Medicine on Stage of Changeful Games of Virtues
|
150 |
Buchvald J.:
Etiopathogenesis and Treatment of Dermatophytoses of the Nails
|
152 |
Geryk E.:
The Possibility of Supporting of Cancer Research and Treatment Respect to its Incidence
|
153 |
